BioNTech Long Term Investments from 2010 to 2024

BNTX Stock  USD 113.51  0.43  0.38%   
BioNTech Long Term Investments yearly trend continues to be fairly stable with very little volatility. Long Term Investments are likely to outpace its year average in 2024. During the period from 2010 to 2024, BioNTech Long Term Investments regression line of annual values had r-squared of  0.38 and arithmetic mean of  167,533,600. View All Fundamentals
 
Long Term Investments  
First Reported
2010-12-31
Previous Quarter
1.2 B
Current Value
1.2 B
Quarterly Volatility
422.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check BioNTech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioNTech's main balance sheet or income statement drivers, such as Tax Provision of 243 M, Net Interest Income of 367.2 M or Interest Income of 375.5 M, as well as many indicators such as Price To Sales Ratio of 5.69, Dividend Yield of 0.011 or PTB Ratio of 1.19. BioNTech financial statements analysis is a perfect complement when working with BioNTech Valuation or Volatility modules.
  
Check out the analysis of BioNTech Correlation against competitors.

Latest BioNTech's Long Term Investments Growth Pattern

Below is the plot of the Long Term Investments of BioNTech SE over the last few years. Long Term Investments is an item on the asset side of BioNTech balance sheet that represents investments BioNTech SE intends to hold for over a year. BioNTech SE long term investments may include different instruments such as stocks, bonds, real estate and cash. It is BioNTech's Long Term Investments historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioNTech's overall financial position and show how it may be relating to other accounts over time.
Long Term Investments10 Years Trend
Slightly volatile
   Long Term Investments   
       Timeline  

BioNTech Long Term Investments Regression Statistics

Arithmetic Mean167,533,600
Geometric Mean0.00
Coefficient Of Variation251.94
Mean Deviation276,791,707
Median66,000
Standard Deviation422,076,053
Sample Variance178148.2T
Range1.2B
R-Value0.61
Mean Square Error119883.7T
R-Squared0.38
Significance0.02
Slope57,804,661
Total Sum of Squares2494074.7T

BioNTech Long Term Investments History

20241.2 B
20231.2 B
202280.2 M
202121.3 M
2019null
201818 K
201719 K

About BioNTech Financial Statements

BioNTech investors use historical fundamental indicators, such as BioNTech's Long Term Investments, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioNTech. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Long Term Investments1.2 B1.2 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for BioNTech Stock Analysis

When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.